Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, 710069, Shaanxi, China.
College of Chemistry & Materials Science, Northwest University, Xi'an, 710127, Shaanxi, China.
J Nanobiotechnology. 2022 Dec 31;20(1):547. doi: 10.1186/s12951-022-01760-8.
Cancer immunotherapy has shown promising therapeutic results in the clinic, albeit only in a limited number of cancer types, and its efficacy remains less than satisfactory. Nanoparticle-based approaches have been shown to increase the response to immunotherapies to address this limitation. In particular, magnetic nanoparticles (MNPs) as a powerful manipulator are an appealing option for comprehensively regulating the immune system in vivo due to their unique magnetically responsive properties and high biocompatibility. This review focuses on assessing the potential applications of MNPs in enhancing tumor accumulation of immunotherapeutic agents and immunogenicity, improving immune cell infiltration, and creating an immunotherapy-sensitive environment. We summarize recent progress in the application of MNP-based manipulators to augment the efficacy of immunotherapy, by MNPs and their multiple magnetically responsive effects under different types of external magnetic field. Furthermore, we highlight the mechanisms underlying the promotion of antitumor immunity, including magnetically actuated delivery and controlled release of immunotherapeutic agents, tracking and visualization of immune response in real time, and magnetic regulation of innate/adaptive immune cells. Finally, we consider perspectives and challenges in MNP-based immunotherapy.
癌症免疫疗法在临床上显示出有希望的治疗效果,但仅限于少数几种癌症类型,其疗效仍不尽如人意。基于纳米颗粒的方法已被证明可以提高免疫疗法的反应,以解决这一限制。特别是,由于其独特的磁响应特性和高生物相容性,磁性纳米颗粒(MNPs)作为一种强大的操纵器,是一种有吸引力的选择,可以全面调节体内的免疫系统。本综述重点评估了 MNPs 在增强免疫治疗剂的肿瘤积累和免疫原性、改善免疫细胞浸润和创造免疫治疗敏感环境方面的潜在应用。我们总结了基于 MNP 的操纵器在增强免疫疗法效果方面的最新进展,包括 MNPs 及其在不同类型外磁场下的多种磁响应效应。此外,我们强调了促进抗肿瘤免疫的机制,包括磁驱动的免疫治疗剂的传递和控制释放、实时跟踪和可视化免疫反应,以及固有/适应性免疫细胞的磁性调节。最后,我们考虑了基于 MNP 的免疫疗法的观点和挑战。
J Nanobiotechnology. 2022-12-31
Adv Healthc Mater. 2021-1
Explor Target Antitumor Ther. 2024
Acta Biomater. 2018-12-19
Mater Sci Eng C Mater Biol Appl. 2020-1-28
Pharmaceutics. 2021-11-4
Pharmaceutics. 2023-7-3
Nat Rev Cancer. 2022-7
J Control Release. 2022-1
Mol Aspects Med. 2022-2
J Hematol Oncol. 2021-10-30
Front Pharmacol. 2021-10-4
Front Oncol. 2021-9-23